Literature DB >> 8878826

Chemical biology of isoprenylation/methylation.

R R Rando1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8878826     DOI： 10.1042/bst0240682

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  7 in total

1.  Crystal structure of 5-methylthioribose 1-phosphate isomerase product complex from Bacillus subtilis: implications for catalytic mechanism.

Authors:  Haruka Tamura; Yohtaro Saito; Hiroki Ashida; Tsuyoshi Inoue; Yasushi Kai; Akiho Yokota; Hiroyoshi Matsumura
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

Review 2.  Role of transmethylation reactions in alcoholic liver disease.

Authors:  Kusum K Kharbanda
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.

Authors:  Thangaiah Subramanian; June E Pais; Suxia Liu; Jerry M Troutman; Yuta Suzuki; Karunai Leela Subramanian; Carol A Fierke; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

4.  Statins and the risk of gastric cancer in diabetes patients.

Authors:  Jeeyun Lee; Soo Hyeon Lee; Kyu Yeon Hur; Sook Young Woo; Sun Woo Kim; Won Ki Kang
Journal:  BMC Cancer       Date:  2012-12-13       Impact factor: 4.430

Review 5.  Betaine in Inflammation: Mechanistic Aspects and Applications.

Authors:  Guangfu Zhao; Fang He; Chenlu Wu; Pan Li; Nengzhang Li; Jinping Deng; Guoqiang Zhu; Wenkai Ren; Yuanyi Peng
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

6.  The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials.

Authors:  Hyun Joo Jang; Hyeong Su Kim; Jung Han Kim; Jin Lee
Journal:  J Clin Med       Date:  2018-10-04       Impact factor: 4.241

7.  A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer.

Authors:  S H Lim; T W Kim; Y S Hong; S-W Han; K-H Lee; H J Kang; I G Hwang; J Y Lee; H S Kim; S T Kim; J Lee; J O Park; S H Park; Y S Park; H Y Lim; S-H Jung; W K Kang
Journal:  Br J Cancer       Date:  2015-10-27       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.